Aishwarya Ravindran

3.0k total citations
65 papers, 1.6k citations indexed

About

Aishwarya Ravindran is a scholar working on Physiology, Oncology and Molecular Biology. According to data from OpenAlex, Aishwarya Ravindran has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Physiology, 20 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Aishwarya Ravindran's work include Histiocytic Disorders and Treatments (33 papers), Viral-associated cancers and disorders (11 papers) and Parvovirus B19 Infection Studies (10 papers). Aishwarya Ravindran is often cited by papers focused on Histiocytic Disorders and Treatments (33 papers), Viral-associated cancers and disorders (11 papers) and Parvovirus B19 Infection Studies (10 papers). Aishwarya Ravindran collaborates with scholars based in United States, France and Chile. Aishwarya Ravindran's co-authors include Sanjeev Sethi, Fernando C. Fervenza, Ronald S. Go, M. Cristine Charlesworth, Hanna Dêbiec, Pierre Ronco, LouAnn Gross, Karen L. Rech, Richard J. Smith and Benjamin J. Madden and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Aishwarya Ravindran

58 papers receiving 1.6k citations

Peers

Countries citing papers authored by Aishwarya Ravindran

Since Specialization

Citations

This map shows the geographic impact of Aishwarya Ravindran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aishwarya Ravindran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aishwarya Ravindran more than expected).

Fields of papers citing papers by Aishwarya Ravindran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aishwarya Ravindran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aishwarya Ravindran. The network helps show where Aishwarya Ravindran may publish in the future.

Co-authorship network of co-authors of Aishwarya Ravindran

This figure shows the co-authorship network connecting the top 25 collaborators of Aishwarya Ravindran. A scholar is included among the top collaborators of Aishwarya Ravindran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aishwarya Ravindran. Aishwarya Ravindran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms 2025 ·Leukemia & lymphoma ·Aishwarya Ravindran, Liuyan Jiang, Gordon Ruan, Surendra Dasari, Jithma P. Abeykoon, Saurabh Zanwar, (unknown), (unknown), Jonathan McConathy, N. Nora Bennani, Ronald S. Go, Gaurav Goyal, Karen L. Rech	0
2	Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants 2025 ·Leukemia ·(unknown), Jithma P. Abeykoon, Saurabh Zanwar, Gordon Ruan, Karen L. Rech, Aishwarya Ravindran, N. Nora Bennani, Caroline Davidge‐Pitts, Matthew J. Koster, Jay H. Ryu, Mithun Vinod Shah, W. Oliver Tobin, Robert Vassallo, Jason R. Young, Ronald S. Go, Gaurav Goyal	3
3	Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue: Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics 2025 ·Cancers ·(unknown), Jithma P. Abeykoon, Gaurav Goyal, Ronald S. Go, (unknown), Rebecca L. King, Aishwarya Ravindran	0
4	Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration 2025 ·Haematologica ·Oshrat Hershkovitz‐Rokah, Jithma P. Abeykoon, Aishwarya Ravindran, Gaurav Goyal	0
5	Efficacy of Small Molecule Kinase Inhibitors in Histiocytic Neoplasms with Non-BRAFV600E Mutations: Concordance of Pre-Clinical Predictions to Clinical Responses 2024 ·Blood ·(unknown), (unknown), N. Nora Bennani, Gaurav Goyal, Aishwarya Ravindran, Karen L. Rech, Gordon Ruan, Mithun Vinod Shah, (unknown), Saurabh Zanwar, Jithma P. Abeykoon, Ronald S. Go	1
6	Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis 2024 ·American Journal of Hematology ·Gordon Ruan, Saurabh Zanwar, Aishwarya Ravindran, (unknown), Jithma P. Abeykoon, Antonious Hazim, Jason R. Young, Mithun Vinod Shah, N. Nora Bennani, Liuyan Jiang, Diana Morlote, Karen L. Rech, Gaurav Goyal, Ronald S. Go	9
7	Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations 2024 ·JCO Precision Oncology ·Katherine E. Smith, (unknown), Surendra Dasari, Wasantha Ranatunga, Karen L. Rech, Aishwarya Ravindran, Jason R. Young, Patrick W. McGarrah, Gordon Ruan, Saurabh Zanwar, Jing Li, Julio C. Sartori‐Valinotti, (unknown), Thomas E. Witzig, Gaurav Goyal, Ronald S. Go, Jithma P. Abeykoon	2
8	How I Diagnose Rosai-Dorfman Disease 2023 ·American Journal of Clinical Pathology ·Aishwarya Ravindran, Karen L. Rech	12
9	Long-term outcomes among adults with Langerhans cell histiocytosis 2023 ·Blood Advances ·Gaurav Goyal, (unknown), Jithma P. Abeykoon, Chen Dai, Aishwarya Ravindran, Robert Vassallo, Jay H. Ryu, Mithun Vinod Shah, N. Nora Bennani, Jason R. Young, (unknown), Gordon Ruan, Saurabh Zanwar, W. Oliver Tobin, Matthew J. Koster, Caroline Davidge‐Pitts, Lucinda Gruber, Surendra Dasari, Karen L. Rech, Ronald S. Go	10
10	Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells 2023 ·Modern Pathology ·Aishwarya Ravindran, Surendra Dasari, Gordon Ruan, (unknown), Rong He, David S. Viswanatha, Jithma P. Abeykoon, Saurabh Zanwar, Jason R. Young, Gaurav Goyal, Ronald S. Go, Karen L. Rech	15
11	Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series 2022 ·Kidney International Reports ·Aishwarya Ravindran, Lílian Monteiro Pereira Palma, Fernando C. Fervenza, Sanjeev Sethi	8
12	Aberrant expression of lymphoid enhancer–binding factor 1 in Hodgkin lymphoma 2022 ·Human Pathology ·Aishwarya Ravindran, Paul J. Kurtin, Rebecca L. King, Yuan Ji, Andrew L. Feldman, Karen L. Rech, Ellen D. McPhail, Sameer A. Parikh, Wei Ding, Min Shi	2
13	Ophthalmologic Involvement in Adults with Histiocytic Disorders 2022 ·Ophthalmology ·Samantha A. Banks, M. Tariq Bhatti, Ronald S. Go, Jithma P. Abeykoon, (unknown), Antonious Hazim, Gaurav Goyal, Jason R. Young, Matthew J. Koster, Robert Vassallo, Jay H. Ryu, Caroline Davidge‐Pitts, Aishwarya Ravindran, Julio C. Sartori‐Valinotti, N. Nora Bennani, Mithun Vinod Shah, Karen L. Rech, James A. Garrity, W. Oliver Tobin	2
14	Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival 2021 ·American Journal of Hematology ·Antonious Hazim, Gordon Ruan, Marie Hu, Aishwarya Ravindran, Karen L. Rech, Jason R. Young, Christian W. Cox, Jithma P. Abeykoon, Caleb Scheckel, Robert Vassallo, Jay H. Ryu, W. Oliver Tobin, Matthew J. Koster, N. Nora Bennani, Mithun Vinod Shah, Gaurav Goyal, Ronald S. Go	10
15	In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes 2021 ·Journal of the American Society of Nephrology ·Aishwarya Ravindran, Marta Casal Moura, Fernando C. Fervenza, Samih H. Nasr, Mariam P. Alexander, Mary E. Fidler, Loren P. Herrera Hernandez, Pingchuan Zhang, Joseph P. Grande, Lynn D. Cornell, (unknown), Vivian Negron, (unknown), Benjamin J. Madden, M. Cristine Charlesworth, Sanjeev Sethi	60
16	Exostosin 1/Exostosin 2–Associated Membranous Nephropathy 2019 ·Journal of the American Society of Nephrology ·Sanjeev Sethi, Benjamin Madden, Hanna Dêbiec, M. Cristine Charlesworth, LouAnn Gross, Aishwarya Ravindran, Amber M. Hummel, Ulrich Specks, Fernando C. Fervenza, Pierre Ronco	196
17	Etiologies of Extreme Thrombocytosis: A Contemporary Series 2019 ·Mayo Clinic Proceedings ·Ronan W. Hsieh, Aishwarya Ravindran, C. Christopher Hook, Kebede H. Begna, Aneel A. Ashrani, Rajiv K. Pruthi, Ariela L. Marshall, William J. Hogan, Mark R. Litzow, James D. Hoyer, Jennifer L. Oliveira, Prakash Vishnu, Timothy G. Call, Aref Al‐Kali, Mrinal M. Patnaik, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi, Ronald S. Go	10
18	Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort 2018 ·Nephrology Dialysis Transplantation ·Alvise Berti, Émilie Cornec-Le Gall, Divi Cornec, Marta Casal Moura, Eric L. Matteson, Cynthia S. Crowson, Aishwarya Ravindran, Sanjeev Sethi, Fernando C. Fervenza, Ulrich Specks	54
19	Florid dermatopathic lymphadenopathy—A morphological mimic of Langerhans cell histiocytosis 2018 ·Clinical Case Reports ·Aishwarya Ravindran, Gaurav Goyal, (unknown), Ronald S. Go, Karen L. Rech	9
20	A follow‐up on desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia 2017 ·American Journal of Hematology ·(unknown), Wayne A. Bottner, Aishwarya Ravindran, Ramona S. DeJesus, Ronald S. Go	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact